Abstract
Background and aim
Hematopoietic cytokines (HCs) regulate the proliferation and differentiation of hematopoietic progenitor cells, and it was proved that HCs can promote cancer growth. The aim of this study is to determine whether HCs might be useful in the diagnosis of colorectal cancer.
Materials and methods
We compared the serum levels of stem cell factor (SCF), interleukin 3 (IL-3), granulocyte–macrophage colony-stimulating factor (GM-CSF), and macrophage colony-stimulating factor (M-CSF) in 97 colorectal cancer patients with those in 35 patients with colorectal adenomas and 65 healthy subjects (control group). Additionally, we investigated commonly accepted tumor markers, such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9). HCs were determined using enzyme linked immunosorbent assay (ELISA). CEA and CA 19-9 were measured by microparticle enzyme immunoassay.
Results
Serum levels of GM-CSF, M-CSF, and tumor markers were significantly higher in cancer patients as compared to the control group and adenomas patients. Of these, hematopoietic cytokines were found elevated in the higher proportion of patients than CEA and CA 19-9. The sensitivity of SCF was higher than the sensitivity of other cytokines, but diagnostic specificity and predictive value were highest for M-CSF. Moreover, the M-CSF area under the receiver operating characteristic curve was larger than the areas of other cytokines. The highest values of diagnostic parameters were observed for the combined use of M-CSF with CEA.
Conclusion
The obtained data support the M-CSF usefulness as a tumor marker for colorectal cancer, especially in combination with CEA.
Similar content being viewed by others
References
Gongoll S, Peters G, Mengel M, Piso P, Klempnauer J, Kreipe H, Wasielewski R (2002) Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology 123:1478–1484
Lynch JP, Hoops TC (2002) The genetic pathogenesis of colorectal cancer. Hematol Oncol Clin North Am 16:775–810
Schulmann K (2002) Colonic cancer and polyps. Best Pract Res Clin Gastroenterol 16:91–114
Ahmad NA, Kochman ML, Ginsberg GG (2002) Endoscopic ultrasound and endoscopic mucosal resection for rectal cancers and villous adenomas. Hematol Oncol Clin North Am 16:897–906
Negm RS, Verma M, Srivastava S (2002) The promise of biomarkers in cancer screening and detection. Trends Mol Med 8:288–293
Smith MA, Court EL, Smith JG (2001) Stem cell factor: laboratory and clinical aspects. Blood Rev 15:191–197
Trutmann M, Terracciano L, Noppen C, Kloth J, Kaspar M, Peterli R, Tondelli P, Schaefer Ch, Zajac P, Heberer M, Spagnoli GC (1998) GM-CSF gene expression and protein production in human colorectal cell lines and clinical tumor specimens. Int J Cancer 77:378–385
Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC (1992) Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 80:374–380
McDermott RS, Deneux L, Mosseri V, Vedrenne J, Clough K, Fourquet A, Rodriguez J, Cosset JM, Sastre X, Beuzeboc Ph, Pouillart P, Scholl SM (2002) Circulating macrophage colony stimulating factor as a marker of tumor progression. Eur Cytokine Netw 13:121–127
Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N (1999) Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Br J Cancer 79:40–46
Mroczko B, Szmitkowski M, Okulczyk B (2003) Hematopoietic growth factors in colorectal cancer patients. Clin Chem Lab Med 41:646–651
Mroczko B, Szmitkowski M, Wereszczyñska-Siemiątkowska U, Okulczyk B (2005) Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer. Dig Dis Sci 50:1019–1024
Fleming ID, Cooper JS, Henson DE, Hutter VP, Kennedy BJ, Murphy GP, O’Sullivan B, Sobin LH, Yarbro JW (1997) Colon and rectum. AJCC Cancer Staging Manual. Lippincott-Raven, New York
Jass JR, Sobin LH (1989) Definition and explanatory notes. Large intestine. Histological typing of intestinal tumors. Springer, Berlin Heidelberg New York
Fischer LD, Belle G, Biostatistics (1993) A methodology for the health sciences. Wiley, New York
Lindblom A, Liljegren A (2000) Tumour markers in malignancies BMJ 320:424–427
Dunlop RJ, Campbell CW (2000) Cytokines and advanced cancer. J Pain Symptom Manage 20:214–232
Lahm H, Amstad P, Yilmaz A, Borbenyi Z, Wyniger J, Fischer JR, Suardet L, Givel JC, Odartchenko N (1995) Interleukin 4 down-regulates expression of c-kit and autocrine stem cell factor in human colorectal carcinoma cells. Cell Growth Differ 6:1111–1118
Lahm H, Wyniger J, Hertig S, Yilmaz A, Fischer J, Givel JC, Odartchenko N (1994) Secretion of bioactive granulocyte-macrophage colony-stimulating factor by human colorectal carcinoma cells. Cancer Res 54:3700–3702
Calatayud S, Warner TD, Breese EJ, Mitchell JA (2002) Modulation by colony stimulating factors of human epithelial colon cancer cell apoptosis. Cytokine 20:163–167
Rutkowski P, Kamiñska J, Kowalska M, Ruka W, Steffen J (2002) Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis. Int J Cancer 100:463–471
Kaminska J, Nowacki, MP, Kowalska MM, Rysinska A, Chwalinski M, Fuksiewicz M, Michalski W (2005) Correlation of serum cytokines with clinicopathological features and prognosis in patients with colorectal carcinoma. Soluble sTNF RI an independent prognostic factor. Tumour Biol 26:186–194
Esposito I, Kleeff J, Bischoff SC, Fischer L, Collecchi P, Iorio M, Bevilacqua G, Buchler MW, Friess H (2002) The stem cell factor-c-kit system and mast cells in human pancreatic cancer. Lab Invest 82:1481–1492
Acknowledgement
This work was supported by the State Committee for Scientific Research (KBN) (grant 3 PO5B 02325).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mroczko, B., Szmitkowski, M., Wereszczyńska-Siemiątkowska, U. et al. Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer. Int J Colorectal Dis 22, 33–38 (2007). https://doi.org/10.1007/s00384-006-0099-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-006-0099-4